RX-37

CAS No. 1627715-60-9

RX-37 ( RX 37;RX37;BET bromodomain inhibitor RX-37 )

Catalog No. M12417 CAS No. 1627715-60-9

A potent and specific BET bromodomain inhibitor with Ki of 3.2-24.7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1323 Get Quote
50MG 2682 Get Quote
100MG 3600 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RX-37
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and specific BET bromodomain inhibitor with Ki of 3.2-24.7 nM.
  • Description
    A potent and specific BET bromodomain inhibitor with Ki of 3.2-24.7 nM for BD1 and BD2 domains of BRD2, BRD3, and BRD4; shows an excellent selectivity over other non-BET bromodomain-containing proteins with the exception of CREBBP (Kd=670 nM); potently and selectively inhibits cell growth in human acute leukemia cell lines harboring the rearranged MLL1 gene (IC50=20 nM for MV4;11 cells).
  • Synonyms
    RX 37;RX37;BET bromodomain inhibitor RX-37
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1627715-60-9
  • Formula Weight
    413.48
  • Molecular Formula
    C24H23N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=C(C2=C(C)ON=C2C)C=C(NC3=C4C(C5=C(C)NN=C5C6CC6)=NC=C3)C4=C1
  • Chemical Name
    4-(1-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-8-methoxy-5H-pyrido[4,3-b]indol-7-yl)-3,5-dimethylisoxazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ran X, et al. J Med Chem. 2015 Jun 25;58(12):4927-39.
molnova catalog
related products
  • NI-42

    A potent, selective and orally active BRPF1 bromodomain inhibitor with IC50 of 7.9 nM.

  • BAZ2-ICR

    BAZ2-ICR is a potent, selective and cell-active inhibitor of BAZ2A and BAZ2B bromodomains.

  • CD 161

    A potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively.